Provided by Tiger Trade Technology Pte. Ltd.

Abivax S.A.

113.58
-5.0600-4.27%
Post-market: 113.600.0200+0.02%19:30 EDT
Volume:1.16M
Turnover:132.43M
Market Cap:9.89B
PE:-21.77
High:117.14
Open:116.66
Low:113.20
Close:118.64
52wk High:148.83
52wk Low:69.81
Shares:87.05M
Float Shares:76.46M
Volume Ratio:1.10
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.2168
EPS(LYR):-5.6758
ROE:-157.07%
ROA:-44.65%
PB:19.94
PE(LYR):-20.01

Loading ...

Earning Preview: Abivax S.A. this quarter’s revenue is expected to decrease by 43.05%, and institutional views are mostly bullish

Earnings Agent
·
Yesterday

Abivax Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga Earnings
·
Yesterday

U.S. Research Roundup-Caseys General Stores, Targa Resources, United Rentals

Reuters
·
Sep 10

Abivax Sa: Shares up 2.8% After Gs Initiates at 'Buy'

THOMSON REUTERS
·
Sep 10

Abivax Sa : Goldman Sachs Initiates Coverage with Buy Rating

THOMSON REUTERS
·
Sep 10

Abivax initiated with a Buy at Goldman Sachs

TIPRANKS
·
Sep 10

Abivax Announces Positive Pre-Nda Interaction with the FDA for Obefazimod

THOMSON REUTERS
·
Jul 31

Abivax Sa: Remains on Track to Submit First Nda for Obefazimod for Treatment of Moderately to Severely Active Ulcerative Colitis by End of 2026

THOMSON REUTERS
·
Jul 31

Movement Alert|Abivax S.A. Rises 5.18% in Regular Trading, Morgan Stanley Raises Target Price to $180

Market Focus
·
Jul 30

Abivax's Potential Colitis Drug Showing Positive Results That Bolster Stock Prospects, Morgan Stanley Says

MT Newswires Live
·
Jul 24

Morgan Stanley Adjusts Price Target on Abivax to $180 From $132, Maintains Overweight Rating

MT Newswires Live
·
Jul 24

Abivax Names New Global Heads of Marketing, Sales and Market Access in Commercial Leadership Shake-up

Reuters
·
Jul 24

Abivax re-engages Centerview amid renewed takeover interest, La Lettre says

TIPRANKS
·
Jul 18

Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies

MT Newswires Live
·
Jul 16

Abivax price target raised to $175 from $165 at Piper Sandler

TIPRANKS
·
Jul 09

Abivax Closes $920 Million ADS Offering

MT Newswires Live
·
Jul 07

Abivax Rebounds, but Obefazimod Unlikely to Replace JAK Inhibitors, Wedbush Says

MT Newswires Live
·
Jul 06

Abivax Sa : Wedbush Raises Target Price to $140 from $110

THOMSON REUTERS
·
Jul 06

Wedbush Raises Price Target on Abivax to $140 From $110, Keeps Neutral Rating

MT Newswires Live
·
Jul 06

Movement Alert|Abivax S.A. Rises 6.46% in Pre-Market Trading, $920 Million ADS Offering Officially Closes Boosting Bullish Sentiment

Market Focus
·
Jul 06